Voyager Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
70%
€10.60
Target price
31.12.25
€20.00
Performance (%)
-25.99%
Price
09.05.24
€7.85
Summary
This prediction is currently active. The prediction for Voyager Therapeutics Inc disappoints with a performance of -25.99%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Voyager Therapeutics Inc | -1.321% | -1.321% |
| iShares Core DAX® | 4.015% | 2.971% |
| iShares Nasdaq 100 | 2.755% | 0.503% |
| iShares Nikkei 225® | -0.826% | -5.057% |
| iShares S&P 500 | 2.330% | 0.720% |
According to BiotechBee what are the pros and cons of Voyager Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Voyager Therapeutics Inc diskutieren
Buy mit Kursziel 20,0
Stopped prediction by BiotechBee for Voyager Therapeutics Inc
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€5.62
31.12.22
31.12.22
€15.00
31.08.25
31.08.25
25.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
